Network meta-analysis articleThe paper is not based on a previous communication to a society or meeting.
Conflicts of Interest and Source of Funding:No conflicts of interest. No external funding.Keywords: ischemia-reperfusion injury, hepatectomy, systematic review, ischemic preconditioning, morbidity, blood loss. Excellence Decision Support Unit. Odds ratios for binary outcomes and mean differences for continuous outcomes were calculated using fixed-effect model or random-effects model according to model-fit.Results: Forty four trials with 2457 patients undergone liver resection were included, and were divided into eight classes of interventions aimed at decreasing IR injury and a control group which was surgery alone. There was no significant difference between the different interventions in mortality, quantity of blood transfusion, and Intensive Therapy Unit stay between any pairwise comparison. Patients treated with ischemic preconditioning, cardiovascular modulators, and miscellaneous interventions had significantly fewer serious adverse events compared to patients receiving surgery alone. Ischemic preconditioning patients had significantly fewer transfusion proportions and shorter operative time than patients treated with steroids. Ischemic preconditioning had significantly lower operative blood loss compared to all other interventions, and shorter length of hospital stay than surgery alone. Sensitivity analysis showed that the drugs sevoflurane (a volatile anesthetic), verapamil (a calcium channel blocker), and gabexate mesilate (a thrombin inhibitor) produced fewer serious adverse events compared to surgery alone.
Conclusion:Ischemic preconditioning resulted in multiple beneficial clinical end points and further RCTs are needed to confirm its clinical benefits.